Myogenic nitric oxide synthase activity in canine lower oesophageal sphincter: Morphological and functional evidence

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1055-1064

  Salapatek, Anne Marie F ^a   Wang, Yu Fang ^b   Mao, Yu Kang ^b   Lam, Annette ^b   Daniel, Edwin E ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Calcium; Constitutive nitric oxide synthase; Oesophageal sphincter; Smooth muscle; Tone

Indexed keywords

ARGININE; CALCIUM CHANNEL; CARBACHOL; CITRULLINE; ENZYME ANTIBODY; ISOENZYME; MYOGENIC FACTOR; N(G) NITROARGININE; NIFEDIPINE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE (CALCIUM,CALMODULIN); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRITIUM;

AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ESOPHAGUS MUSCLE; FEMALE; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; INTESTINE INNERVATION; ISOTOPE LABELING; LOWER ESOPHAGUS SPHINCTER; MALE; MUSCLE DEVELOPMENT; MUSCLE FIBER MEMBRANE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE;

ANIMALS; DOGS; ENZYME INHIBITORS; ESOPHAGOGASTRIC JUNCTION; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH; NADPH DEHYDROGENASE; NITRIC OXIDE SYNTHASE; NITROARGININE; PATCH-CLAMP TECHNIQUES;

EID: 0031911999     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701701     Document Type: Article

References (49)

1. 3H]saxitoxin as a marker for canine deep muscular plexus neurons. Am. J. Physiol., 255, G462-469.
2. ALLESCHER, H.D., BEREZIN, I., JURY, J. & DANIEL, E.E. (1988). Characteristics of canine lower esophageal sphincter: a new electrophysiological tool. Am. J. Physiol., 255, G441-453.
3. BEREZIN, I., ALLESCHER, H.-D. & DANIEL, E.E. (1987). Ultrastructural localization of VIP-immunoreactivity in canine distal oesophagus. J. Neurocytology, 16, 749-757.
4. BEREZIN, I., SNYDER, H., BREDT, D.S. & DANIEL, E.E. (1994). Ultrastructural localization of nitric oxide synthase in canine small intestine and colon. Am. J. Physiol., 266, C981-C989.
5. BIANCANI, P., HARNETT, K.M., SOHN, U.D., RHIM, B.Y., BEHAR. J., HILLEMAN, C. & BITAR, K.N. (1994). Differential signal transduction pathways in LES tone and response to ACh. Am. J. Physiol., 266, G767-774.
6. BREDT, D.S. & SNYDER, S.H. (1989). Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 86, 9030-9033.
7. BREDT, D.S. & SNYDER, S.H. (1994). Nitric oxide: A physiologic messenger molecule. Ann. Rev. Biochem., 63, 175-195.
8. CATTERALL, W.A. (1995). Structure and function of voltage-gated ion channels. Ann. Rev. Biochem., 64, 493-531.
9. + channel opening mediates hyperpolarization by NO donors and inhibitory junction potentials in opossum esophagus Am. J. Physiol., 268, G831-842.
10. CAYABYAB, F.S., JIMENEZ, M., VERGARA, P., DE BRUIN, H. & DANIEL, E.E. (1997). Influence of nitric oxide and vasoactive intestinal peptide on the spontaneous and triggered electrical and mechanical activities of the canine ileum. Can. J. Physiol. Pharmacol., (in press).
11. DANIEL, E.E. (1992). Lower esophagus: structure and function. In Sphincters: Normal Function - Changes in Diseases. eds Daniel, E.E., Tomita, T., Tsuchida, S. & Watanabe, M. pp. 49-66. Boca Raton, Florida: Raven, CRC Press.
12. DANIEL, E.E., HAUGH, C., WOSKOWSKA, Z., CIPRIS, S., JURY, J. & FOX-THRELKELD, J.E.T. (1994). Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. Am. J. Physiol., 266, G31-G39.
13. DE BELDER, A.J., RADOMSKE, M.W., WHY, H.F.J., RICHARDSON, P.J., BUCKNALL, C.A., SALAS, E., MARTIN, J.F. & MONCADA, S. (1993). Nitric oxide synthase activities in human myocardium. Lancet, 341, 84-85.
14. DE MAN, J.G., PELCKMANS, P.A., BOEKXSTAENS, G.E., BULT, H., OOSTERBOSCH, L., HERMAN, A.G. & VAN MAERCKE, Y.M. (1991). The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br. J. Pharmacol., 103, 1092-1096.
15. DOGIEL, A.S. (1899). Über den Bau der Ganglien in den Geflechten des Darmes und der Gallenblase des Menschen und der Säugetiere. Arch. Anat. Physiol., 1899, 130-158.
16. EBASHI, S. (1991). Excitation-contraction coupling and the mechanism of muscle contraction. Ann. Rev. Physiol., 53, 1-16.
17. FÖRSTERMANN, U., CLESS, E.I., POLLOCK, J.S., NAKANE, M., SCHWARZ, P., GATH, I. & KLEINERT, H. (1994). Nitric oxide synthase isozymes. Hypertension, 23, 1121-1131.
18. FRIEDLAND, G.W., KOHATSU, S. & LEWIN, K. (1971). Comparative anatomy of feline and canine gastric sling fibers. Analogy to human anatomy. Am. J. Dig. Dis., 16, 495-507.
19. GRIDER, J.R. & JIN, J-G. (1993). VIP-induced nitric oxide (NO) production and relaxation in isolated muscle cells of the gut in human and other mammalian species. (Abstract). Gastroenterology, 104, A515.
20. HASSALL, C.J.S. & BURNSTOCK, G. (1986). Intrinsic neurones and associated cells of the guinea-pig heart in culture. Brain Res., 364, 102-113.
21. HOPE, B.T. & VINCENT, S.R. (1989). Histochemical characterization of neuronal NADPH-diaphorase. J. Histochem. Cytoehem., 37, 653-661.
22. HRYHORENKO, L.M. & FOX-THRELKELD, J.E.T. (1994). Tonic nitric oxide (NO) release inhibits field stimulated (FS) acetylcholine (ACH) release from canine ileal myenteric plexus free circular muscle. J. Pharmacol. Exp. Ther., 271, 918-926.
23. JANSSEN, L.J. & SIMS, S.M. (1992). Acetylcholine activates non-selective cation and chloride conductances in canine and guineapig tracheal myocytes. J. Physiol., 453, 197-218.
24. JING, L., INOUE, R., TAHIRO, K., TAKAHASHI, S. & ITO, Y. (1995). Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway. J. Physiol., 483, 225.
25. JOHANSSON, B. (1989). Myogenic tone and reactivity: definitions based on muscle physiology. J. Hypertension, 7, S5-S8.
26. JURY, J., AHMEDZADEH, N. & DANIEL, E.E. (1991). A mediator derived from arginine mediates inhibitory junction potentials and relaxations in lower esophageal sphincter: an independent role from vasoactive intestinal peptide. Can. J. Physiol. Pharmacol., 70, 1182-1189.
27. JURY, J. & DANIEL, E.E. (1997). Lack of electrophysiological effect of VIP on canine LES opossum LES and opossum BCM. Gastroenterology, 112, A757.
28. KONTUREK, J.W., THOR, P., LUKASZYK, A., GABRYELEWICZ, A., KONTUREK, S.J. & DOMSCHKE, W. (1997). Endogenous nitric oxide in the control of esophageal motility in humans. J. Physiol. Pharmacol. (Poland), 48, 201-209.
29. KOSTKA, P., JANG, E., WATSON, E.G., STEWART, J. & DANIEL, E.E. (1993). Nitric oxide synthase in the autonomic nervous system of canine ileum. J. Pharmacol. Exp. Ther., 264, 234-239.
30. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. MAO, Y.-K., WANG, Y.-F. & DANIEL, E.E. (1993). Distribution and characterization of VIP binding in canine lower esophageal sphincter. Gastroenterology, 105, 1370-1377.
32. MAO, Y.-K., WANG, Y.-F. & DANIEL, E.E. (1994). Canine LES cells and perhaps interstitial cells of cajal (ICC) contain cNOS; it is not nNOS. (Abstract). Gastroenterology, 107, 1231.
33. MCCLESKEY, E.W., FOX, A.P., FELDMAN, D.H., CRUZ, L.J., OLIVERA, B.M., TSIEN, R.W. & YOSHIKAMI, D. (1987). ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. U.S.A., 84, 4327-4331.
34. MONCADA, S. (1992). The L-arginine:nitric oxide pathway. Acta Physiol. Scand., 145, 201-227.
35. MURRAY, J.A., DU, C., LEDLOW, A., MANTERNACH, P.L. & CONKLIN, J.L. (1992). Guanylate cyclase inhibitors: effect on tone, relaxation, and cGMP content of lower esophageal sphincter. Am. J. Physiol., 263, G97-101.
36. i1-2. J. Biol. Chem., 269, 15977-15980.
37. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am. J. Physiol., 265, G660-G671.
38. NY, L., ALM, P., LARSSON, B., EKSTRÖM, P. & ANDERSSON, K.-E. (1995). Nitric oxide pathway in cat esophagus: localization of nitric oxide synthase and functional effects. Am. J. Physiol., 268, G59-G70.
39. POLLOCK, J.S., JAKANE, M., BUTTERY, L.D., MARTINEZ, A., SPRINGALL, D., PLAK, J.A., FÖRSTERMANN, U. & MURAD, F. (1993). Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am. J. Physiol., 265, C1379-C1387.
40. PREIKSAITIS, H.G., TREMBLAY, L. & DIAMANT, N.E. (1994). Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig. Dis. Sci., 39, 770-775.
41. SALAPATEK, A.M. & DANIEL, E.E. (1994). Novel calcium handling in canine lower esophageal sphincter smooth muscle. (Abstract). Gastroenterology, 106, A1049.
42. SALAPATEK, A.M.F. & DANIEL, E.E. (1995). Modulation of canine lower esophageal sphincter tone by nitric oxide synthase in muscle. (Abstract). Gastroenterology, 108, A681.
43. SALAPATEK, A.M.F., FOX-THRELKELD, J.E.T. & DANIEL, E.E. (1996). Mechanism of nitric oxide-induced LES relaxation involves intracellular calcium modulation. (Abstract). Gastroenterology, 110, A750.
44. SINGARAM, C., SENGUPTA, A., SWEET, D.J. & GOYAL, R.K. (1994). Nitrinergic and peptidergic innervation of the human oesophagus. Gut. 35, 1690-1696.
45. TORPHY, T.J., FINE, C.F., BURMAN, M., BARNETTE, M.S. & ORMSBEE, III. H.S. (1986). Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content. Am. J. Physiol., 251, G786-G793.
46. VAN BREEMEN, C., CHEN, Q. & LAHER, I. (1995). Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol. Sci., 16, 98-104.
47. WATANABE, M. (1992). General properties of sphincters. In Sphincters: Normal function - Changes in Diseases, ed. Daniel, E.E., Tomita, T., Tsuchida, S. & Watanabe, M. pp. 3 5, Boca Raton. Florida: Raven, CRC Press.
48. WILCOX, C.S., WELCH, W.J., MURAD., F., GROSS, S.S., TAYLOR, G., LEVI, R. & SCHMIDT, H.H. (1992). Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc. Natl. Acad. Sci. U.S.A., 89, 11993-11997.
49. YALLAMPALLI, C., IZUMI, H., BYAM-SMITH, M. & GARFIELD, R.E. (1994). An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am. J. Obstetrics Gynecology, 170, 175-185.